Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Frontiers in Oncology|May 23, 2022
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast CancerFang Chen, Jian-Yue Jin, Timothy S K Hui, et al.Frontiers in Oncology|May 31, 2021
Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric SurrogatesCheng Zhou, Changguo Shan, Mingyao Lai, et al.International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?Feng-Ming Spring Kong, Vitali Moiseenko, Jing Zhao, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexusFeng-Ming Spring Kong, Timothy Ritter, Douglas J Quint, et al.JAMA Oncology|September 26, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular CarcinomaChi Leung Chiang, Kenneth Sik Kwan Chan, Keith Wan Hang Chiu, et al.Journal of the National Cancer Center|March 5, 2025
Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinomaCai-Ning Zhao, Chi-Leung Chiang, Wan-Hang Keith Chiu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2020
Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancerYongmei Liu, Weili Wang, Kevin Shiue, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationshipPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2023
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineationGeng-Min Niu, Miao-Miao Gao, Xiao-Feng Wang, et al.Signal Transduction and Targeted Therapy|May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programmingLaiyan Zhou, Yuanxin Liu, Zherui Xing, et al.Pageof 16